4519 中外製薬

4519
2025/02/18
時価
12兆4317億円
PER
31.46倍
2009年以降
13.93-46.43倍
(2009-2024年)
PBR
6.41倍
2009年以降
1.33-10倍
(2009-2024年)
配当 予
3.38%
ROE
20.37%
ROA
17.54%
資料
Link
CSV,JSON

新株予約権、売上原価、未払法人税等他2件

【期間】
年度新株予約権売上原価未払法人税等在外子会社等の為替換算差額基本的1株当たり四半期利益
2007/121.39億----
2008/123.26億 +134.5%1270億114億--
2009/125.36億 +64.4%1929億 +51.8%221億 +94.6%--
2010/127.75億 +44.6%1624億 -15.8%36.8億 -83.4%--
2011/1210.2億 +31%1575億 -3%142億 +284.8%--
2012/1212.2億 +20.1%1677億 +6.5%119億 -16.3%--
2013/1214.2億 +16.7%1924億 +14.7%129億 +8.6%--
2014/1214.6億 +2.2%2145億 +11.5%165億 +28.4%--
2015/1215.3億 +5.2%2404億 +12.1%131億 -21%--
2016/1218.4億 +20.1%2448億 +1.8%102億 -21.9%--
2017/1217.3億 -5.9%2552億 +4.3%200億 +96.7%--
2018/1214.4億 -16.8%2644億 +3.6%201億 +0.2%-31.6億169.08円/株
2019/1212.2億 -14.9%2635億 -0.4%421億 +109.4%-11.7億 赤縮287.84円/株 +70.24%
2020/126.22億 -49.2%2689億 +2.1%653億 +55.2%14.7億 黒転130.66円/株 -54.61%
2021/125.28億 -15.1%3351億 +24.6%888億 +36%30.2億 +106%184.29円/株 +41.05%
2022/121.9億 -64%4728億 +41.1%1024億 +15.3%55.4億 +83.3%227.64円/株 +23.52%
2023/121.25億 -34.2%4066億 -14%422億 -58.7%70.1億 +26.6%197.83円/株 -13.1%
2024/12---45.9億 -34.6%235.39円/株 +18.99%